Shenfu Jianxing Launches RMB 100 Million Brain-Spinal Interface Project in Waigaoqiao, Accelerating Industrialization of Implantable Neuromodulation Systems

Stock trading depends onGolden Qilin Analyst Report, authoritative, professional, timely, comprehensive, help you explore potential thematic opportunities!

(Source: Shanghai Observer)

The reporter learned that,WaigaoqiaoThe region ushers in another significant project: Shenfu Jianxing (Shanghai) Medical Device Co., Ltd. has launched the construction of its R&D and production headquarters in the Waigaoqiao New Exhibition City Park. With a total investment of approximately 100 million yuan and a building area of 7,100 square meters, this comprehensive base will focus on the industrialization of implantable cerebrospinal neural stimulation systems.

At the same time, another brain-computer interface company in the region, StairMed, in collaboration with a scientific research team, has made a major breakthrough in the second invasive brain-computer interface clinical trial. The patient successfully controlled an electric wheelchair and a robotic dog through thought, achieving a historic leap in brain control ability from "two-dimensional screens" to the "three-dimensional physical world."

Currently, brain-computer interface technology is rapidly moving from laboratories to industrial applications, becoming a core track in global technological competition. Shanghai has taken the lead in introducing an industry cultivation plan, clearly aiming to promote the clinical application of semi-invasive products and achieve key breakthroughs in invasive technologies by 2027, with the goal of creating a global innovation hub for brain-computer interface products by 2030. Industry-leading enterprises are accelerating their industrial layout and innovation pace in areas such as Waigaoqiao, continuously enhancing the core competitiveness of Pudong New Area's brain-computer interface industry.

Gathering of upstream and downstream enterprises to improve the industrial layout of brain-computer interface

As a key enterprise in the Waigaoqiao brain-computer interface industry, Shenfujianxing is accelerating the advancement of the implantable "brain-spine interface" technology in collaboration with Fudan University. Unlike traditional "brain-computer interfaces," which control external devices to replace limb functions, this technology restores direct communication between the brain and spinal cord by repairing neural pathways, offering the possibility of regaining motor function for patients with spinal cord injuries.

Dr. Jia Fumin, founder of Shenfu Jianxing, stated that he hopes within the next five years, more patients with spinal cord injuries will no longer rely on wheelchairs but instead achieve "free running" using their own legs.

It is reported that, in order to achieve this goal, StairMed plans to promote the clinical implementation of its core products and the production of new product lines by 2026, while simultaneously launching wearable simulation.RobotR&D, Making the Rehabilitation Miracle of "Walking Out of the Hospital Post-Surgery" a Norm.

Another industry leader — StairMed — continues to make significant progress in the field of invasive brain-computer interfaces. StairMed has now completed a Series B+ round of financing worth hundreds of millions of yuan, making it the second company globally, after Neuralink, to enter the clinical stage in the field of invasive brain-computer interfaces. Its "Implantable Wireless Brain-Computer Interface System" has become the first system of its kind in China to receive approval from the National Medical Products Administration (NMPA).Innovative HealthcareProducts of the same category with "Special Review Procedure for Devices" qualification.

From the agglomeration of industrial resources to the support of physical space, Waigaoqiao is continuously optimizing the foundation of its industrial ecosystem, providing solid support for project implementation and development.

A relevant official from New Development Co., Ltd, a subsidiary of Waigaoqiao Group, stated that the New Exhibition City 3.0 Industrial Community is committed to providing innovative enterprises with comprehensive support ranging from spatial carriers to industrial services. The full-chain supporting system, covering research and development, testing, production, and logistics, aligns closely with the development needs of high-tech industries such as brain-computer interface.

Currently, Xinzhan City has gathered over 200 global leading enterprises. The settlement of StairMed will further improve Xinzhan City's industrial layout in the brain-computer interface field. The construction of its R&D and production headquarters will not only attract more upstream and downstream enterprises to gather but also form deep collaboration with existing clinical institutions and research teams in the region.

Collaborate in the construction and pilot projects of national-level open platforms to create an innovative experimental field with greater international competitiveness.

Waigaoqiao Always Focuses on System Innovation as the CoreDriving Force, and explore service supply models that align with the characteristics of cutting-edge technology industries. In response to the long research and development cycle and the significant challenges in clinical translation for brain-computer interface technologies, relevant units in Waigaoqiao actively facilitate communication channels between research institutions, enterprises, and regulatory authorities. This effort aims to accumulate practical experience for policy breakthroughs in frontier industry sectors, accelerating the transformation of innovative achievements and the market entry process of products.

Last November, Waigaoqiao officially launched the "Brain-Computer Interface Innovation and Development Partnership Program," providing comprehensive support to enterprises from four key dimensions: cross-border R&D innovation, full-cycle R&D and market entry assistance, domestic and international market expansion, and specialized financial and talent services. Subsequently, a review of more than a hundred brain-computer interface-related enterprises and institutions across China was conducted to identify key target customers covering the entire chain from chip materials to application services.

Brain-computer interface is on the verge of an explosion as it moves from laboratory to clinical application. Waigaoqiao not only provides enterprises with "industrial fertile ground" and "innovation air," but also, through the "Brain-Computer Interface Innovation Development Partnership Program," is systematically building a full-chain empowerment ecosystem, creating a cluster effect, and seizing the commanding heights of the future industry.

Reporters learned that Waigaoqiao has jointly built laboratories with top clinical institutions such as the Seventh People's Hospital of Shanghai and Oriental Hospital. By constructing a full-chain empowerment system of "clinical-capital-policy," they have established a special investment channel in collaboration with multiple industrial funds, initiating health economics and outcome research on brain-computer interfaces to pave the way for industrial commercialization.

As the construction of the Oriental Hub International Business Cooperation Zone continues to advance, Waigaoqiao will further leverage its regional synergy advantages and actively participate in the development and pilot programs of national-level open platforms. By integrating global resources, it will help brain-computer interface companies overcome bottlenecks such as cross-border data flow and customs clearance for R&D samples. At the same time, it will collaborate with medical institutions in Pudong New Area to establish clinical trial bases, offering dedicated guidance for the registration of innovative medical devices, thereby assisting companies in expanding into global markets and creating a more internationally competitive innovation test bed and industrial ecosystem.

Author of Shangguan Channel: Pudong Observation